Bharat Biotech begins clinical trials of TB vaccine 'MTBVAC' on adults in India

Mar 24, 2024

As per Bharat Biotech, MTBVAC is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company, Biofabri.

Research institute plans to study whether BCG vaccine booster dose can reduce TB burden

Jul 04, 2022

New Delhi [India], July 5 : The country's apex tuberculosis (TB) research institute has planned a study to assess whether a booster dose...

Tuberculosis vaccine may help in reducing Covid-19 deaths: Study

Jul 10, 2020

Washington D.C. [USA], July 10 : A century-old tuberculosis vaccine may play a role in reducing death due to Covid-19 infection, a preliminary study...

India may get effective vaccine against tuberculosis in 2024, says ICMR-NARI scientist

Mar 31, 2022

New Delhi [India], March 31 : India may get an effective vaccine against tuberculosis (TB) in 2024 that will reduce the burden of its...

Harsh Varshan seeks cooperation of global community in development of TB vaccine

Jun 16, 2021

New Delhi [India], June 17 : Union Minister of Health and Family Welfare, Dr Harsh Vardhan sought cooperation from the global community in the...

Gates Foundation set for first large-scale tuberculosis vaccine trial: CEO Mark Suzman

Jan 27, 2024

The people who get tuberculosis are largely poor people who can't pay for treatments. That's an example of an investment that is not focused...